Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02747641 · ClinicalTrials.gov registry record · NA
Prospective, Open-Label, Single-Center, Non-Comparative Study to Assess the Use of Pixel CO2 Laser System (FemiLift) in the Treatment of Vulvovaginal Atrophy (VVA) in Postmenopausal Female Subjects
A NA study of Vaginal Atrophy and Atrophy, sponsored by Alma Lasers.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT02747641: Completed NA study of Vaginal Atrophy and Atrophy, sponsored by Alma Lasers.
NCT02747641 is a NA study of Vaginal Atrophy and Atrophy that has completed, run by Alma Lasers. The registered enrollment target is 15 participants, below the 355-participant average among 9 other Vaginal Atrophy trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02747641, a NA study of Vaginal Atrophy and Atrophy, has completed, sponsored by Alma Lasers.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the use of the Alma CO2 Pixel FemiLift™ in the treatment of VulvoVaginal Atrophy (VVA) in postmenopausal female subjects. The primary endpoint is to assess the change in the vaginal dryness by means of a Visual Analogic Scale (10 cm VAS) and/or Bachmann Index in VVA. The clinical improvement will be assessed by patient filled Vulvovaginal Atrophy.
Primary Outcome
Utilizing Bachman Vaginal Health Index
Conditions Studied
Interventions
- PROCEDURE Pixel CO2 Laser System
Study Locations (1)
Florida
- The Cleveland Clinic - Weston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2016-05 |
| Est. Completion | 2017-08 |
| Phase | NA |
What the finished NCT02747641 record still lists
NCT02747641 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 355-participant average among 9 other Vaginal Atrophy trials with a reported enrollment target (96% lower).
The record links to 3 conditions, with Vaginal Atrophy appearing as the primary indexed condition, and to 1 intervention - of which Pixel CO2 Laser System is the first listed.
NCT02747641 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT02747641 about?
NCT02747641 is a clinical study titled "Prospective, Open-Label, Single-Center, Non-Comparative Study to Assess the Use of Pixel CO2 Laser System (FemiLift) in the Treatment of Vulvovaginal Atrophy (VVA) in Postmenopausal Female Subjects". The purpose of this study is to assess the use of the Alma CO2 Pixel FemiLift™ in the treatment of VulvoVaginal Atrophy (VVA) in postmenopausal female subjects. The primary endpoint is to assess the change in the vaginal dryness by means of a Visual Analogic Scale (10 cm VAS) and/or Bachmann Index i...
What is the current status of trial NCT02747641?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2016-05. Estimated completion is 2017-08.
What conditions does trial NCT02747641 study?
This clinical trial studies the following conditions: Vaginal Atrophy, Atrophy, Genital Diseases, Female.
What interventions are being tested in trial NCT02747641?
The interventions under investigation include: Pixel CO2 Laser System (PROCEDURE).
Who is sponsoring clinical trial NCT02747641?
This trial is sponsored by Alma Lasers, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02747641 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vaginal Atrophy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02747641's enrollment target sits among peer trials
15 9th of 9 higher than 1 of 9 other Vaginal Atrophy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Vaginal Atrophy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
VALOR: Vaginal Atrophy & Long-term Observation of Recovery
RECRUITING · NA
-
PRP Injections for Genitourinary Syndrome of Menopause
ACTIVE NOT RECRUITING · NA
-
Hybrid Fractional Laser for Symptoms of Genitourinary Syndrome of Menopause
COMPLETED · NA
-
Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo
RECRUITING · Phase 4
-
Postpartum Vaginal Estrogen for Breastfeeding Patients
RECRUITING · Phase 4
-
ASSIST-VLA: Assessment of Symptom-Specific Improvement in Diagnosed Vaginal Atrophy Following Laser Therapy
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia